Answers are grounded in this paper and cite their sources.
Case report demonstrates that adjunctive therapy improves immune homeostasis in empyema and neuroinflammation.
BACKGROUND/AIM: ) therapy. CASE REPORT: -facilitated apoptotic clearance of pro-inflammatory lineages. Conversely, the helper T-cell (Th) reservoir was preserved. Recovery was further characterized by the consistent restoration of intermediate and post-germinal center memory B-cell populations, coupled with a substantial augmentation of suppressive T and B-cell subsets (Tregs and Bregs). This shift toward immune homeostasis prevented secondary autoimmune flares and facilitated successful discharge. CONCLUSION: as a promising adjuvant therapy for complex infectious and neuroinflammatory conditions.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: